Virax Biolabs Group Limited (VRAX) Stock Price, Quote & News

Company Profile

Virax Biolabs Group Limited, a biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics. The company offers various in-vitro diagnostics test kits comprising respiratory, pregnancy and fertility, infectious diseases, sti, drugs of abuse, oncology, cardiac, women's health, other test kits under the ViraxClear brands; and rapid and molecular tests for small animal veterinary...

Industry: Biotechnology

Sector: Healthcare

Phone: 44 20 7788 7414

Website: viraxbiolabs.com

Address:

BioCity Glasgow, Bo’Ness Road Newhouse, Lanarkshire, United Kingdom

Begin298 Apr. 4 at 4:29 PM

$VRAX https://fintel.io/s/us/vrax 17 Feb 2026 ARMISTICE CAPITAL, LLC increased to owning 9.99%. $VRAX

0 · Reply

Begin298 Apr. 4 at 12:46 PM

$VRAX Thoughts on upcomming week. Time to get a good position here I think. With the RS, low float and results coming the upside is undeniable. The market cap also does not reflect their cash on hand, RND ect. This is undervalued and seems to have been pushed down by shorts likely. Also with the insider buying for March.

1 · Reply

dawsondesign Apr. 2 at 8:17 PM

$VRAX hello, short bus sirs? Covering or what? That’s a still a move out the downtrend channel… lemme know thanx

1 · Reply

dawsondesign Apr. 2 at 8:06 PM

$VRAX big wall, I’ll give it a sec- otherwise this will be the rager for next week and will re-enter

0 · Reply

dawsondesign Apr. 2 at 7:37 PM

$VRAX & $RDGT for AH

0 · Reply

Joshr1371 Apr. 2 at 6:03 PM

$VRAX Someone is accumulating size without chasing price

1 · Reply

nottoday800 Apr. 2 at 2:29 PM

$VRAX reverse split has to be anyday now..

1 · Reply

thattradeguy_ Apr. 2 at 12:14 PM

$VRAX

0 · Reply

321rip Apr. 2 at 8:25 AM

$VRAX check out $AIXI

0 · Reply

waled_khal Apr. 2 at 3:17 AM

$VRAX

0 · Reply

What's Behind The Jump In Virax Biolabs Stock?

Mar 31, 2026, 7:34 AM EDT - 5 days ago

Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation

Dec 4, 2025, 4:05 PM EST - 4 months ago

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement

Dec 3, 2025, 1:53 PM EST - 4 months ago

Virax Biolabs Group Limited Announces $5 Million Private Placement

Dec 3, 2025, 7:34 AM EST - 4 months ago

Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders

Nov 3, 2025, 8:29 AM EST - 5 months ago

Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes

Aug 26, 2025, 7:30 AM EDT - 7 months ago

Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September

Jul 29, 2025, 7:35 AM EDT - 8 months ago

Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy

Jul 18, 2025, 4:15 PM EDT - 9 months ago

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Mar 31, 2025, 2:57 PM EDT - 1 year ago

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating

Mar 18, 2025, 7:30 AM EDT - 1 year ago

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Mar 13, 2025, 7:30 AM EDT - 1 year ago

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Mar 5, 2025, 7:30 AM EST - 1 year ago

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Feb 25, 2025, 7:00 AM EST - 1 year ago

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Jan 23, 2025, 3:35 PM EST - 1 year ago

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

COSM

Jan 13, 2025, 9:20 AM EST - 1 year ago

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

COSM

Dec 17, 2024, 7:30 AM EST - 1 year ago

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Dec 10, 2024, 7:30 AM EST - 1 year ago

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Oct 23, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Sep 16, 2024, 8:30 AM EDT - 1 year ago

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

COSM

Sep 16, 2024, 8:30 AM EDT - 1 year ago

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

COSM

Sep 9, 2024, 8:00 AM EDT - 1 year ago

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Aug 29, 2024, 9:03 AM EDT - 1 year ago

Virax Biolabs to Participate at 7th European Congress of Immunology

Aug 28, 2024, 2:18 PM EDT - 1 year ago

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know

Aug 28, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Aug 23, 2024, 4:09 PM EDT - 1 year ago

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 9:30 PM EDT - 1 year ago

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 10:20 AM EDT - 1 year ago

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

COSM

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Apr 16, 2024, 7:30 AM EDT - 2 years ago

Virax Biolabs to Participate at ESCMID Global 2024

Dec 21, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Dec 14, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Sep 12, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Sep 1, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Aug 3, 2023, 7:30 AM EDT - 2 years ago

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Jul 18, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

May 4, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

Apr 19, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Mar 10, 2023, 5:17 PM EST - 3 years ago

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 8, 2023, 8:55 AM EST - 3 years ago

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 7, 2023, 7:30 AM EST - 3 years ago

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Feb 7, 2023, 9:15 AM EST - 3 years ago

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

COSM

Feb 7, 2023, 8:30 AM EST - 3 years ago

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

COSM

Feb 6, 2023, 4:05 PM EST - 3 years ago

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Jan 4, 2023, 7:30 AM EST - 3 years ago

Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

Dec 6, 2022, 7:30 AM EST - 3 years ago

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Nov 15, 2022, 7:30 AM EST - 3 years ago

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Nov 8, 2022, 4:30 PM EST - 3 years ago

Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement

Nov 4, 2022, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Announces $3.8 Million Private Placement

Nov 3, 2022, 7:30 AM EDT - 3 years ago

Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

Begin298 Apr. 4 at 4:29 PM

$VRAX https://fintel.io/s/us/vrax 17 Feb 2026 ARMISTICE CAPITAL, LLC increased to owning 9.99%. $VRAX

0 · Reply

Begin298 Apr. 4 at 12:46 PM

1 · Reply

dawsondesign Apr. 2 at 8:17 PM

$VRAX hello, short bus sirs? Covering or what? That’s a still a move out the downtrend channel… lemme know thanx

1 · Reply

dawsondesign Apr. 2 at 8:06 PM

$VRAX big wall, I’ll give it a sec- otherwise this will be the rager for next week and will re-enter

0 · Reply

dawsondesign Apr. 2 at 7:37 PM

$VRAX & $RDGT for AH

0 · Reply

Joshr1371 Apr. 2 at 6:03 PM

$VRAX Someone is accumulating size without chasing price

1 · Reply

nottoday800 Apr. 2 at 2:29 PM

$VRAX reverse split has to be anyday now..

1 · Reply

thattradeguy_ Apr. 2 at 12:14 PM

$VRAX

0 · Reply

321rip Apr. 2 at 8:25 AM

$VRAX check out $AIXI

0 · Reply

waled_khal Apr. 2 at 3:17 AM

$VRAX

0 · Reply

321rip Apr. 2 at 1:44 AM

$VRAX looks like yest. HI set 2 b in rear view mirror

0 · Reply

Twills08 Apr. 2 at 12:11 AM

$VRAX This was a recent runner. Now consolidated off of catalyst. Elliott wave impulse structure intact and uptrending with volume into AH. I would keep an eye here. There is 20-30% profit to be had imo.

1 · Reply

waled_khal Apr. 1 at 11:46 PM

$VRAX

0 · Reply

WannabeTrad3r Apr. 1 at 11:32 PM

$VRAX Holding 5k Shares might buy more tomorrow unless it hits PT ;)

1 · Reply

KBTD Apr. 1 at 9:26 PM

$VRAX

0 · Reply

waled_khal Apr. 1 at 9:10 PM

$VRAX Short-Term Momentum/Rebound: After experiencing a significant decline earlier in the day (roughly -13.6%), the stock often sees traders looking for a rebound, buying at a lower entry point. Speculative Momentum Following Upgrades: Earlier in early 2026, Virax was upgraded to a buy rating based on earnings estimate revisions. Investors often trade the stock based on these technical signals

0 · Reply

waled_khal Apr. 1 at 9:09 PM

$VRAX Here are the logical reasons for the movement: Recent ISO Certifications (Fundamental Catalyst): VRAX shares showed momentum following an announcement that its UK subsidiary, Virax Biolabs (UK) Limited, received ISO 13485:2016 and ISO 9001:2015 certifications. These certifications validate their quality management system for the development of immunological assay components, crucial for their diagnostic technology and T cell immune-profiling platform. High Volatility and Low Float (Technical Factors): VRAX has been experiencing significant, rapid price movements (39%+ fluctuations in a single session). Because the stock has low liquidity and a small float, minor buying pressure can create outsized price jumps, especially in after-hours trading

0 · Reply

Begin298 Apr. 1 at 9:04 PM

$VRAX what is going on with it?

0 · Reply

TeeTee111122 Apr. 1 at 8:56 PM

$VRAX whoa

0 · Reply

Yung_Ball3R Apr. 1 at 8:21 PM

$VRAX

0 · Reply

Joshr1371 Apr. 1 at 8:09 PM

$VRAX Flush → Absorption → Stabilization High volume + no breakdown 2x average volume BUT price held structure Absorption (smart money buying panic) Previous panic zone ~$0.15 Today held ~$0.165 Subtle but important: Higher lows starting Reclaimed key level Stayed around $0.19–$0.20 That was resistance before Now acting like support It FAILED at ~$0.205 That’s now short-term resistance It’s not a breakout yet — just stabilization Capitulation → buyers stepped in

0 · Reply

321rip Apr. 1 at 8:04 PM

$VRAX looks like today's LO marked end of p/b

0 · Reply

Market Cap	756,000.00
Revenue (ttm)	10,000.00
Net Income (ttm)	-6.06M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-60,600.00%
Debt to Equity Ratio	0.04

Volume	2,444,000
Avg Vol	5,183,070
Day's Range	N/A - N/A
Shares Out	4.34M
Stochastic %K	17%
Beta	1.61
Analysts	Sell
Price Target	$1.00